{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15656140", "DateCompleted": {"Year": "2005", "Month": "06", "Day": "03"}, "DateRevised": {"Year": "2008", "Month": "02", "Day": "06"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"ISSN": "1001-5302", "JournalIssue": {"Volume": "29", "Issue": "11", "PubDate": {"Year": "2004", "Month": "Nov"}}, "Title": "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", "ISOAbbreviation": "Zhongguo Zhong Yao Za Zhi"}, "ArticleTitle": "[Protective effect of jasminoidin on cascade of damage of cerebral ischemia in rats].", "Pagination": {"StartPage": "1065", "EndPage": "1068", "MedlinePgn": "1065-8"}, "Abstract": {"AbstractText": ["To study the protective effect of jasminoidin on cascade of damage of cerebral ischemia.", "The rats were randomly divided into four groups: sham-operated group, ischemic group, the jasminoidin-treatment group and PNS-treatment group. Focal cerebral ischemia was produced by permanent occlusion of left middle cerebral artery (PMCAO) in rats. Radioimmunoassay (RIA) was utilized to identify the content of tumor necrosis factor-alpha (TNF-alpha) and interlukin 1beta (IL-1beta) in brain tissue of rats following ischemia. and that of Neuron-specific enolase (NSE) in rat's serum was observed too. The plasma concentration of vonWillebrand factor (vWF) was identified by enzyme-linked immunoadsordent assay (ELISA).", "After 12 h and 24 h of ischemia, the contents of TNF-alpha and IL-1beta and vWF as well as on NSE showed concomitant increase. Jasminoidin dramatically inhibited the increase of TNF-alpha and IL-1beta after 12 h and 24 h of ischemia, and repressed the increase of vWF after 12 h and 24 h of ischemia too. However, the influence of jasminodin NSE after 12 h and 24 h of ischemia was not significant.", "Jasminoidin had good effect on repressing the expression of TNF-alpha and IL-1beta as well as vWF caused by cerebral ischemia, thus it manifested the effect of relieving the damage to vascular endothelial cell and blocking the progress of cascade damage of cerebral ischemia through inhibiting the process of inflammation."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. zephyr9527@163.com"}], "Identifier": [], "LastName": "Zhu", "ForeName": "Xiao-lei", "Initials": "XL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "Na", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Li", "ForeName": "Peng-tao", "Initials": "PT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jiang", "ForeName": "Yu-feng", "Initials": "YF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Xu", "ForeName": "Ya", "Initials": "Y"}], "PublicationTypeList": ["English Abstract", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhongguo Zhong Yao Za Zhi", "NlmUniqueID": "8913656", "ISSNLinking": "1001-5302"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-1"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "0", "NameOfSubstance": "von Willebrand Factor"}, {"RegistryNumber": "EC 4.2.1.11", "NameOfSubstance": "Phosphopyruvate Hydratase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Brain"}, {"QualifierName": ["etiology", "metabolism"], "DescriptorName": "Brain Ischemia"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Gardenia"}, {"QualifierName": ["complications", "metabolism"], "DescriptorName": "Infarction, Middle Cerebral Artery"}, {"QualifierName": ["blood"], "DescriptorName": "Interleukin-1"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["blood"], "DescriptorName": "Phosphopyruvate Hydratase"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Random Allocation"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Saponins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}, {"QualifierName": ["metabolism"], "DescriptorName": "von Willebrand Factor"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2005", "Month": "1", "Day": "20", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "6", "Day": "4", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "1", "Day": "20", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15656140"]}}], "PubmedBookArticle": []}